While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms ...

Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and treatment limitations.

The proportion of people being diagnosed with early-onset Parkinson’s is on the rise. Dr Victor Dieriks lays out four ...

Bemdaneprocel is administered by surgical transplantation into a part of the brain known as the putamen, in the hope of ...

Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...

Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms ...

People who move around in bed and appear to 'act out' dreams could be exhibiting an early sign of dementia or Parkinson's ...